Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

DNA Binding Studies on Several New Anthracycline Antitumor Antibiotics II. The Importance of the Carbomethoxy-group at Position-10 of the Class II Anthracycline Molecule

VIRGIL H. DUVERNAY JR., JONATHAN A. PACHTER and STANLEY T. CROOKE
Molecular Pharmacology September 1979, 16 (2) 623-632;
VIRGIL H. DUVERNAY JR.
The Bristol-Baylor Laboratory, Department of Pharmacology, Baylor College of Medicine, Houston, Texas 77030
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JONATHAN A. PACHTER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STANLEY T. CROOKE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 16 no. 2 623-632
PubMed 
514262

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Published online September 1, 1979.

Copyright & Usage 
Copyright © 1979 by Academic Press, Inc.

Author Information

  1. VIRGIL H. DUVERNAY JR.,
  2. JONATHAN A. PACHTER, and
  3. STANLEY T. CROOKE
  1. The Bristol-Baylor Laboratory, Department of Pharmacology, Baylor College of Medicine, Houston, Texas 77030
  2. Bristol Laboratories, Syracuse, N.Y. 13201

Statistics from Altmetric.com

Article usage

Article usage: September 2005 to March 2021

AbstractFullPdf
Sep 2005100
Oct 2005100
Dec 2005201
Mar 2006300
Apr 2006100
May 2006100
Sep 2006600
Oct 2006605
Nov 2006502
Dec 2006500
Jan 2007600
Feb 2007200
Mar 2007400
Apr 2007202
May 2007100
Jun 2007602
Jul 2007100
Aug 2007300
Sep 2007300
Oct 2007001
Nov 2007700
Dec 2007500
Jan 2008100
Feb 2008501
Mar 2008501
Apr 2008100
May 2008101
Jun 2008901
Jul 2008400
Aug 2008300
Sep 20081000
Oct 2008500
Nov 2008901
Dec 2008400
Jan 20091000
Feb 2009600
Mar 2009601
Apr 20091000
May 20091600
Jun 2009500
Jul 2009400
Aug 2009400
Sep 2009700
Oct 20091200
Nov 20091000
Dec 2009800
Jan 2010400
Feb 2010800
Mar 2010200
Apr 2010601
May 20101100
Jun 2010100
Jul 2010200
Aug 2010800
Sep 2010500
Oct 2010500
Nov 2010500
Dec 2010500
Jan 2011800
Feb 20111802
Mar 2011300
Apr 2011100
May 2011500
Jun 2011800
Jul 20111300
Aug 2011500
Sep 2011600
Oct 20111000
Nov 2011900
Dec 20111500
Jan 20121200
Feb 20121601
Mar 20121500
Apr 20121301
May 2012801
Jun 2012902
Jul 2012900
Aug 2012900
Sep 2012900
Oct 20121100
Nov 2012200
Dec 2012504
Jan 20131200
Feb 20131700
Mar 2013900
Apr 20132100
May 20131200
Jun 2013100
Jul 2013200
Aug 2013301
Sep 2013100
Oct 2013900
Nov 2013400
Dec 2013700
Jan 2014400
Feb 2014400
Mar 2014100
Apr 2014200
May 2014100
Jun 2014300
Jul 2014211
Aug 2014500
Sep 2014801
Oct 20142400
Nov 2014500
Dec 20141600
Jan 2015501
Feb 2015100
Mar 2015601
May 2015200
Jun 2015500
Jul 2015600
Aug 2015700
Sep 2015700
Oct 2015500
Nov 2015100
Dec 2015200
Jan 2016400
Feb 20165301
Mar 2016601
Apr 2016201
May 2016201
Jun 2016200
Jul 2016200
Aug 2016100
Sep 2016400
Oct 2016100
Nov 2016200
Dec 2016500
Jan 2017300
Feb 2017100
Mar 2017100
Apr 2017600
May 2017800
Jun 2017300
Jul 20171100
Aug 2017900
Sep 2017500
Oct 20171100
Nov 2017700
Dec 2017800
Jan 2018900
Feb 2018800
Mar 2018200
Apr 2018600
May 2018200
Jun 2018700
Jul 2018200
Aug 2018400
Sep 2018100
Oct 2018400
Nov 2018100
Dec 2018400
Jan 2019300
Feb 2019600
Mar 2019200
May 2019400
Jun 2019304
Jul 2019100
Aug 2019200
Sep 2019800
Oct 2019700
Nov 2019800
Dec 2019800
Jan 2020200
Feb 2020500
Mar 2020200
Apr 2020300
May 2020100
Jun 2020900
Jul 2020200
Oct 2020100
Nov 2020500
Dec 2020600
Jan 2021900
Feb 2021900
Mar 2021100

PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 16, Issue 2
1 Sep 1979
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
DNA Binding Studies on Several New Anthracycline Antitumor Antibiotics II. The Importance of the Carbomethoxy-group at Position-10 of the Class II Anthracycline Molecule
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

DNA Binding Studies on Several New Anthracycline Antitumor Antibiotics II. The Importance of the Carbomethoxy-group at Position-10 of the Class II Anthracycline Molecule

VIRGIL H. DUVERNAY, JONATHAN A. PACHTER and STANLEY T. CROOKE
Molecular Pharmacology September 1, 1979, 16 (2) 623-632;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

DNA Binding Studies on Several New Anthracycline Antitumor Antibiotics II. The Importance of the Carbomethoxy-group at Position-10 of the Class II Anthracycline Molecule

VIRGIL H. DUVERNAY, JONATHAN A. PACHTER and STANLEY T. CROOKE
Molecular Pharmacology September 1, 1979, 16 (2) 623-632;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Identification of Celecoxib targets by label-free TPP
  • Editing TOP2α Intron 19 5′ SS Circumvents Drug Resistance
  • CTS Bias
Show more Articles

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics